Agilent Technologies, Inc. - Diagnostics and Genomics SSELXT2 Human All Exon V7, 16 rxn
The Agilent SureSelectXT2 Human All Exon V7, 16 reactions (5191-4007) is a target enrichment solution designed for next-generation sequencing (NGS) applications. This kit enables comprehensive exome sequencing by capturing all protein-coding regions of the human genome, facilitating the identification of genetic variants associated with disease. The V7 design incorporates the latest genomic content from GENCODE and RefSeq databases, ensuring up-to-date coverage. The SureSelectXT2 workflow is optimized for high-throughput, automation-friendly protocols, and delivers high specificity and uniformity for reliable variant detection in research and clinical studies.